The results suggested that overexpression of GLUT1 in proliferating cancer cells was associated with the abnormal activation of the PI3KC1-AKT pathway, consequent to the mutational activation of PI3KC1 and/or the loss of PTEN [37]. Here, SLC2A1 is linked to cancer.